William Slikker Jr.
President
(2012–2013)

US Food and Drug Administration (US FDA)
National Center for Toxicological Research (NCTR)

Experience: Dr. Slikker is currently the Director of the US FDA’s National Center for Toxicological Research (NCTR) and an Adjunct Professor of Pediatrics and Pharmacology & Toxicology at UAMS. He has served as President of the Teratology Society and the Academy of Toxicological Sciences. In addition, Dr. Slikker also has served on advisory panels for HESI/ILSI, CIIT, US EPA, NIEHS, NIH, NAS, and WHO.

Lois D. Lehman-McKeeman
Vice President
(2012–2013)

Bristol-Myers Squibb Company

Experience: Dr. Lois Lehman-McKeeman is currently a Distinguished Research Fellow in Discovery Toxicology at the Bristol-Myers Squibb Company in Princeton, New Jersey. She was employed in the Human and Environmental Safety Division of the Procter and Gamble Company for 15 years prior to joining Bristol-Myers Squibb in 2001. Dr. Lehman-McKeeman has active research interests and programs broadly in biochemical mechanisms of toxicity, with emphasis on secondary mechanisms of carcinogenesis. She is also working to develop and apply metabonomic and transcriptomic technologies to mechanistic toxicology. She has published extensively in these fields. She has been active professionally in the Society of Toxicology (SOT) serving on numerous SOT committees, and she held elective office in the SOT as Councilor from 2000–2002 and the SOT Awards Committee (2008–2010). In 2003 she was appointed Editor of Toxicological Sciences, a position she currently holds, and she serves on a number of other editorial boards.

Norbert E. Kaminski
Vice President-Elect
(2012–2013)

Michigan State University

Experience: Dr. Kaminski is a professor of pharmacology and toxicology and director of the Center for Integrative Toxicology at Michigan State University. He holds joint appointments in the College of Human Medicine and Veterinary Medicine at Michigan State University. Dr. Kaminski joined the Michigan State faculty in 1993. Dr. Kaminski held the rank of assistant professor at the Medical College of Virginia in the Department of Pharmacology and Toxicology from 1985-1999. He received his doctorate degree in toxicology and physiology from North Carolina State University in1985 and his master’s degree from North Carolina State University in toxicology in 1981. He is a founding member of the Editorial Board for Nonlinearity in Biology, Toxicology and Medicine, and is currently on the editorial board for the journals Toxicology and Journal of Immunotoxicology. Dr. Kaminski served as a member of Council as well as Chair of the Membership Committee for the Society on NeuroImmune Pharmacology. He also serves on the Board of Trustee for the International Life Sciences Institute (ILSI) Health and Environmental Sciences Institute (HESI) and currently serves as treasurer. He has been a member of various advisory panels including the National Academy of Sciences and the US EPA Science Advisory Board and has also served on numerous peer review panels.

John B. Morris
Treasurer
(2011–2013)

University of Connecticut

Experience: Dr. Morris is Professor and Head, Pharmaceutical Sciences Department, and Assistant Dean for Research at the University of Connecticut School of Pharmacy. His research focuses on inhalation dosimetry and quantitative inhalation risk assessment. He has served on editorial boards on Toxicological Sciences and Inhalation Toxicology and advisory panels for NIH, US EPA, DOE, and NAS/NRC.

Denise Robinson Gravatt
Treasurer-Elect
(2012–2014)

Pfizer

Experience: Dr. Robinson Gravatt is currently a senior director and head of science and technology in Drug Safety R&D at Pfizer in Groton, Connecticut. She is responsible for broad science-based research strategies across the global Pfizer organization to address long-standing safety issues related to drug development. These research strategies encompass internal laboratory research and external technology development and investment strategies, including postdoctoral fellowships, external collaborations and other partnerships. Prior to joining Pfizer in 2002, Dr. Robinson Gravatt was the founding director of the ILSI Health and Environmental Sciences Institute, a non-profit organization devoted to advancing the application of toxicological sciences to risk assessment and risk management. She serves on the Advisory Committee of the Critical Path Institute’s Predictive Safety Testing Consortium, the Steering Committee and Scientific Advisory Committee for Innovative Medicine Initiative’s SAFE-T Consortium, and Program Committee for Toxicology Forum. She obtained her doctorate degree in pharmacology from Georgetown University in 1986.

Judith T. Zelikoff
Secretary
(2012–2014)

New York University School of Medicine

Experience: Dr. Zelikoff has extensive experience in an advisory and leadership capacity as reflected by her membership on two National Institutes of Health Study Sections. She is member of the National Institutes of Health College of Scientific Reviewers, National Academy of Science Committees, the National Toxicology Program (Board Member) Scientific Advisory Board, a NASA Moon Dust Panel (Chair), United Nations Atmospheric Brown Cloud Human Health Effects Panel, and the New Jersey Department of Environmental Protection Human Health Committee. Dr. Zelikoff is heavily involved with students both in teaching (three graduate courses in toxicology and immunotoxicology) and in mentoring of masters, doctoral, and postdoctoral trainees in the area of developmental immunotoxicology of inhaled smoke mixtures and nanomaterials. In addition, as Director of Community Outreach for the NYU Department of Environmental Medicine NIEHS Center, she led a laboratory research mentorship program for high school and college students. Dr. Zelikoff has organized a number of international and national meetings in immunotoxicology, as well as developed immunotoxicology courses, in India, Thailand, New Zealand, and Australia.

Jon C. Cook
Past President
(2012–2013)

Pfizer Global Research and Development

Experience: Dr. Cook is a Senior Director of Investigative Toxicology at Pfizer Inc. Before coming to Pfizer in 1998, he was Senior Research Toxicologist at DuPont-Haskell Laboratory for two years and before that, served as Postdoctoral Fellow, CIIT. He received his Bachelor’s degree in Physiology in 1979 from the University of California, Davis and his Master’s degree in Toxicology from North Carolina State University in 1982. In 1985, Dr. Cook received his PhD in Toxicology from North Carolina State University.

Lorrene Buckley
Councilor
(2012–2014)

Eli Lilly & Company

Experience: Dr. Buckley earned her master’s degree in toxicology at the University of Arizona and her doctorate degree at the University of North Carolina, Chapel Hill. Dr. Buckley’s diversity of professional experience as a toxicologist is reflected in her work spanning basic research on the inhalation toxicity of industrial chemicals, toxicology and risk assessment in the agro-chemical industry, and pharmaceutical safety assessment. In her current position as research fellow at Eli Lilly & Company, she is responsible for the design and execution of nonclinical safety assessment programs as well as for nonclinical aspects of global regulatory submissions and interactions for a variety of drugs in the development and commercialization phases. Dr. Buckley holds elected positions serving in the Society of Toxicology and the American College of Toxicology.

Donald A. Fox
Councilor
(2010–2013)

University of Houston

Experience: Dr. Fox is a Professor of Vision Sciences, Biology and Biochemistry, and Pharmacology at the University of Houston. He also is a Keck Faculty Member of The Gulf Coast Consortia, and a Fellow of the Academy of Toxicological Sciences (ATS) and of the Association for Research in Vision and Ophthalmology (ARVO). Dr. Fox is President of the International Neurotoxicology Association, Past President of the Neurotoxicology Specialty Section of SOT, and past Chair of Retinal Cell Biology Program Committee for ARVO. Dr. Fox is an Associate Editor of Toxicology and Applied Pharmacology 2002–present, Associate Editor of Environmental Health Perspectives 2008–Present, Associate Editor of Journal of Ocular Pharmacology and Toxicology 2004–present, past Associate Editor of NeuroToxicology 1986–1996 and an Editorial Board Member of Cutaneous and Ocular Pharmacology 2005–Present and Molecular Vision 1995–present. Dr. Fox received the Frank R. Blood Award from SOT in 1992 for the best paper published in TAAP, University of Houston Research Excellence Award in 1992, and Prominent Teaching Professor Awards at the University of Houston. He has served on National Toxicology Program Scientific Advisory Committee on Alternative Toxicological Methods 2005–2009; NIH/US FDA Advisory Panel on Ocular Toxicology for ICCVAM and NICETAM 2004–2006; National Academy of Sciences/National Research Council Committees on Vision and Safe Drinking Water 1982–1995; US FDA Advisory Committees; NIEHS Study Sections for Toxicology, Minority and ARCH Grants, and Superfund Grants from 1994–2005. He has mentored 20+ PhD and Master’s Students. Dr. Fox is the PI on NIH, NIOSH and private grants and has written over 75 peer-reviewed publications, book chapters, and technical reports.

Dori R. Germolec
Councilor
(2011–2013)

Experience: Dr. Germolec currently serves as the Immunology discipline leader for the National Toxicology Program (NTP), and directs the NTP’s efforts to design, interpret and report studies that assess the potential for chemicals to modulate immune responses. She is particularly interested in persistent immunologic effects following in utero chemical exposure. She also serves as a project leader for toxicology studies and is leading the NTP research efforts to evaluate the health effects of exposure to molds. Dr. Germolec served as the group leader of the Environmental Immunology Laboratory within the Laboratory of Molecular Toxicology at the National Institute of Environmental Health Sciences from 1995–2005. Her research interests include: investigating the interaction between environmental, industrial, and pharmacologic agents and the immune system, and defining the cellular and molecular role of cytokines in toxicity in a variety of organ systems including the skin, lung, and liver.

John C. Lipscomb
Councilor
(2011–2013)

Federal Scientist

Experience: Dr. Lipscomb is a toxicologist and risk assessor. His activities and interests center on replacing default options with science-based decisions. He has over 20 years experience in toxicology and risk assessment, including the US EPA, US FDA/NCTR and uniformed service in the US Air Force. He has published 62 articles, 10 book chapters, 31 government reports, edited a text on Toxicokinetics and Risk Assessment, written risk assessment guidance for the US EPA and the WHO’s International Programme on Chemical Safety, and served as a technical advisor to the American Water Works Association for its research on drinking water disinfection byproducts.

Ivan Rusyn
Councilor
(2012–2014)

Experience: Dr. Rusyn is a professor in the Department of Environmental Sciences and Engineering at the University of North Carolina. From 2007–2010, he was an Associate Professor with tenure at the University. He is a member of the Curriculum in Toxicology at UNC and is the director of the Carolina Center for Computational Toxicology at the UNC Gillings School of Global Public Health. He is a full member of the UNC Lineberger Comprehensive Cancer Center, Bowles Center for Alcohol Studies, the Center for Environmental Health and Susceptibility, and the Carolina Center for Genome Sciences. He received his doctorate degree from the University of North Carolina, Chapel Hill and his medical degree with honors from the Ukrainian State Medical University in 1994.

Michael P. Waalkes
Councilor
(2010–2013)

Experience: Dr. Waalkes has worked for the National Cancer Institute from 1983–present. He was the recipient of the SOT Achievement Award in 1990. Dr. Waalkes serves on the Chief Inorganic Carcinogenesis Section from 1992–present and he is detailed to NIEHS from 1996–present. He has written 340 Publications and is Editor for TAAP from 2000–present. Dr. Waalkes has received a number of awards such as the NIH Merit Award in 2000, the special award for Outstanding Contributions to SOT in 2003, and the Metals Specialty Section Career Achievement Award in 2007. Dr. Waalkes was the Associate Editor of EHP from 2008–present and currently serves on the Editorial Advisory Board for CRT from 2009–present.

Shawn Douglas Lamb
Executive Director

Experience: Deputy Director and Executive Director of SOT since 1991. President, Association Innovation and Management (AIM), an association management company providing administrative services to the toxicology community, including the International Union of Toxicology (IUTOX), Teratology Society (TERA), Academy of Toxicological Sciences (ATS), Safety Pharmacology Society (SPS), Society of Toxicologic Pathology (STP), Environmental Mutagen Society (EMS) and the International Association of Environmental Mutagen Societies (IAEMS). She received her BIS in Business Communications, George Mason University, 1989.